A Phase I Study Targeting Newly Diagnosed Glioblastoma with anti-CD3 × anti-EGFR Bispecific Antibody Armed T cells (EGFR BATs) in Combination with Radiation and Temozolomide

IRB/UVA Tracking #
20105
Contact
Heather L Lothamer
Contact Email
Contact Phone
1.434.924.9924
Phase
I
Primary purpose
Treatment
Cancer PI
Camilo Fadul
Status
OPEN TO ACCRUAL
Ages
Adult